Amid uncertainty over payouts for infringement for design patents, Columbia Sportswear's recent multimillion-dollar trial win in a case over cold-weather gear has been a source of hope for patent owners, and is among a handful of cases that may signal where the law is headed.
The U.S. recording industry has sued 532 people accused of illegal file sharing, in a legal move targeting U.S. universities.
Microsoft blasted the E.U.'s €497.2 million antitrust ruling, claiming it would infringe its intellectual property rights.
Intellectual property specialist firm McAndrews, Held & Malloy has promoted five of its attorneys to its partnership, the firm said.
Endo Pharmaceuticals said Wednesday it would get 180-day market exclusivity for its generic versions of 10 milligram, 20 mg. and 40 mg. of the painkiller OxyContin.
Mylan is suing Procter & Gamble and Watson Pharma, claiming that their "authorized generic" deal for the Macrobid antibiotic violates Mylan's 180-day exclusivity period.
Two New York City intellectual property boutiques have merged following the death last year of one of the firm’s name partners.
National law firm Foley & Lardner has absorbed Bay Area intellectual property boutique Swiss Law Group and opened a Silicon Valley practice.
Shire Pharmaceuticals Group Plc, the U.K.'s third-largest drugmaker, will spend up to $31 million to buy global patent rights to its kidney-failure drug Fosrenol from AnorMED, the company said.
Generic drug maker Andrx Corp. has relinquished its right to a 180-day period of marketing exclusivity for the 150mg strength of Wellbutrin SR(R), a best-selling antidepressant from GlaxoSmithKline.
Gibson Guitar has won a trademark-infringement lawsuit against instrument manufacturer Paul Reed Smith.
Indian drug maker Dr. Reddy's Laboratories has filed an abbreviated new drug application with the United States Food and Drug Administration for levetiracetam, a generic form of Belgian pharmaceutical company UCB's epilepsy drug Keppra.
A downgrade of David Bowie’s “Bowie bonds” to near-junk status raises questions about the future of intellectual property securitization, observers say.
In a suit involving five disputed “business method” patents, Florists' Transworld Delivery (FTD) has asked a judge to declare that its websites do not infringe five e-commerce patents held by automated-teller machine and data warehouse-software concern NCR Corp.
The U.S. Court of Appeals for the Federal Circuit has vacated a lower court’s patent infringement judgment against IXYS in a lawsuit filed by larger rival International Rectifier Corp. over power chips.
In a widely expected move, U.S. President George W. Bush has decided to nominate Jon Dudas, the acting head of the U.S. Patent and Trademark Office, to take over as the permanent director of the agency.
Firing another legal volley in its assault on a controversial form of online advertising, contact lens retailer 1-800-Contacts has sued a competitor that bought advertisements designed to pop up when consumers visit its website.
GlaxoSmithKline has lost a U.K. patent challenge from generic drug makers Cipla and Ivax on its top-selling athma drug Seretide (Advair).
A New York judge refused to dismiss a lawsuit by Jones Apparel Group Inc. against Polo Ralph Lauren in a legal dispute over Polo’s attempt reacquire the license to the Lauren clothing brand.
Alston & Bird has added eight patent, trademark, and copyright attorneys to its New York office from Coudert Brothers, including the head of Coudert’s worldwide IP practice.
A panel at the U.S. Patent and Trademark Office has dealt a setback to Advanced Cell Technology Corp. in interference proceedings initiated by biotech rival Geron Corp. over the animal cloning technology that led to the cloning of Dolly the Sheep.